OKYO Pharma Director John Brancaccio Buys 5,000 Shares At An Average Price Of $1.61, Raising Total Holdings to 31,201

John Brancaccio, Non-Executive Director of OKYO Pharma Limited, has purchased 5,000 shares of the company at an average price of $1.61 per share. This acquisition increases his total holdings to 31,201 shares. OKYO Pharma is a clinical-stage biopharmaceutical company focused on developing therapies for neuropathic corneal pain and inflammatory eye diseases.